Research Topics
Species | G IgnatyevSummaryAffiliation: State Research Center of Virology and Biotechnology Vector Country: Russia Publications
| Collaborators
|
Detail Information
Publications
Experimental study on the possibility of treatment of some hemorrhagic feversG Ignatyev
State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, 633159, Koltsovo, Russia
J Biotechnol 83:67-76. 2000..5 ml (2000 U ml(-1); 1 U of the antiserum neutralises 0.03 ng of TNF-alpha), everyday, within 6 days from the third day after the challenge...
Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003Alena V Atrasheuskaya
State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region, Russia
Vaccine 25:4651-8. 2007..Our results demonstrate the importance of assaying for neutralizing antibody and support the assertion that antigenic differences between wild type and vaccine MuV strains may play a role in cases of breakthrough infection in vaccinees...
Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virusA V Atrasheuskaya
Laboratory of Immunology Safety, Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
Vaccine 24:1530-6. 2006..The L-3 mumps vaccine virus can be shed and transmitted horizontally, even to subjects previously vaccinated with the same virus...
Measles in Minsk, Belarus, 2001-2003: clinical, virological and serological parametersA V Atrasheuskaya
Laboratory of Immunology Safety, Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
J Clin Virol 34:179-85. 2005..The absence of information on measles virus genotypes circulating in the Republic of Belarus has made it difficult to asses the situation...
Acute infectious mononucleosis and coincidental measles virus infectionA V Atrasheuskaya
Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
J Clin Virol 31:160-4. 2004..Recognizing the infectious etiology of concomitant infections is important for both clinicians and epidemiologists...
Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c miceA V Atrasheuskaya
State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
Clin Exp Immunol 136:207-14. 2004..The successful cytokine treatment schemes in this orthopoxvirus model system may have important implications in the treatment of viral diseases in humans and, in particular, of variola virus infection...
Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004A V Atrasheuskaya
State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
Clin Microbiol Infect 13:670-6. 2007..Consistent with previous reports, mumps virus genotypes C and H continue to circulate in Novosibirsk...
Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005A V Atrasheuskaya
State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
Vaccine 26:2111-8. 2008....
Pathogenesis of infectious disease of mice caused by H5N1 avian influenza virusV A Evseenko
Vector State Research Center of Virology and Biotechnology, Novosibirsk Region, Koltsovo, Russia
Bull Exp Biol Med 146:766-9. 2008..Clinical, morphological, and immunological characteristics of the experimental infection caused by highly pathogenic A/duck/Tuva/01/06/ (H5N1) virus are described...
Changes in immune parameters and their correction in human cases of tick-borne encephalitisA V Atrasheuskaya
State Research Centre of Virology and Biotechnology (Vector, Koltsovo, Novosibirsk Region, Russia
Clin Exp Immunol 131:148-54. 2003..Children had the highest levels of IL-6, which were not neurotoxic...
Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogenLarisa I Karpenko
The Joint Stock Company Vector Best, The State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, 630559 Koltsovo, Russia
Vaccine 22:1692-9. 2004..The most significant responses were produced when pcDNA-TCI was delivered by Salmonella...
Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigensSergei I Bazhan
The State Research Center of Virology and Biotechnology Vector, 630559 Koltsovo, Novosibirsk Region, Russia
Vaccine 22:1672-82. 2004..It has been demonstrated that DNA vaccine can induce both specific T cell responses (CTL and blast transformation) and specific antibodies in mice immunized with pcDNA-TCI...
Construction of artificial virus-like particles exposing HIV epitopes, and the study of their immunogenic propertiesLarisa I Karpenko
The State Research Center of Virology and Biotechnology Vector, The Joint Stock Company Vector Best 630559, Novosibirsk Region, Koltsovo, Russia
Vaccine 21:386-92. 2003..The dsRNA and the proteins were linked with spermidine-polyglucin-glutathione conjugates. Particles exposing HIV-1 epitopes were constructed, and their immunogenicity tested...
Experimental infection of H5N1 HPAI in BALB/c miceVasily A Evseenko
State Research Center of Virology and Biotechnology Vector of Rospotrebnadzor, Koltsovo, Russia
Virol J 4:77. 2007..In 2006 several outbreaks have occurred. To develop new vaccines and antiviral therapies, animal models had to be investigated. We choose highly pathogenic strain for these studies...
